- Home
- BRKR vs TEM Comparison
BRKR vs TEM Comparison
Compare BRKR & TEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRKR
- TEM
- Stock Information
- Founded
- BRKR 1991
- TEM 2015
- Country
- BRKR United States
- TEM United States
- Employees
- BRKR N/A
- TEM N/A
- Industry
- BRKR Biotechnology: Laboratory Analytical Instruments
- TEM
- Sector
- BRKR Industrials
- TEM
- Exchange
- BRKR Nasdaq
- TEM NYSE
- Market Cap
- BRKR 9.2B
- TEM 6.3B
- IPO Year
- BRKR 2000
- TEM 2024
- Fundamental
- Price
- BRKR $61.26
- TEM $31.83
- Analyst Decision
- BRKR Buy
- TEM Buy
- Analyst Count
- BRKR 13
- TEM 11
- Target Price
- BRKR $75.67
- TEM $57.20
- AVG Volume (30 Days)
- BRKR 1.4M
- TEM 4.0M
- Earning Date
- BRKR 02-11-2025
- TEM 02-17-2025
- Dividend Yield
- BRKR 0.33%
- TEM N/A
- EPS Growth
- BRKR N/A
- TEM N/A
- EPS
- BRKR 2.06
- TEM N/A
- Revenue
- BRKR $3,241,300,000.00
- TEM $640,442,000.00
- Revenue This Year
- BRKR $15.23
- TEM $32.70
- Revenue Next Year
- BRKR $7.52
- TEM $38.77
- P/E Ratio
- BRKR $30.54
- TEM N/A
- Revenue Growth
- BRKR 15.00
- TEM 32.13
- 52 Week Low
- BRKR $48.07
- TEM $22.89
- 52 Week High
- BRKR $94.86
- TEM $79.49
- Technical
- Relative Strength Index (RSI)
- BRKR 58.41
- TEM N/A
- Support Level
- BRKR $58.78
- TEM N/A
- Resistance Level
- BRKR $64.64
- TEM N/A
- Average True Range (ATR)
- BRKR 1.98
- TEM 0.00
- MACD
- BRKR 0.39
- TEM 0.00
- Stochastic Oscillator
- BRKR 59.23
- TEM 0.00
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.
About TEM TEMPUS AI INC
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.